Have a personal or library account? Click to login
Liver Graft versus Host Disease after Allogeneic Peripheral Stem Cell Transplantation: Update on Etiopathogenesis and Diagnosis Cover

Liver Graft versus Host Disease after Allogeneic Peripheral Stem Cell Transplantation: Update on Etiopathogenesis and Diagnosis

Romanian Journal of Internal Medicine
Volume 54 (2016): Issue 2 (June 2016)
By: R.-G. Mihăilă  
Open Access
|May 2016

References

  1. 1. TUNCER HH, RANA N, MILANI C, DARKO A, AL-HOMSI SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. 2012; 18: 1851-1860.10.3748/wjg.v18.i16.1851
    Search in Google Scholar
  2. 2. SCHOLL S, SAYER HG, MÜGGE LO, KASPER C, PIETRASZCZYK M, KLICHE KO, et al. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation. J Cancer Res Clin Oncol. 2004; 130: 704-710.10.1007/s00432-004-0603-6
    Search in Google Scholar
  3. 3. HEALTH QUALITY ONTARIO. Extracorporeal photophoresis: an evidence-based analysis. Ont Health Technol Assess Ser. 2006; 6: 1-82.
    Search in Google Scholar
  4. 4. TEISSEYRE M, TEISSEYRE J, KALICINSKI P, WOLSKA-KUSNIERZ B, ISMAIL H, BERNATOWSKA E, et al. Liver transplantation for severe hepatic graft-versus-host disease in two children after hematopoietic stem cell transplantation. Transplant Proc. 2010; 42: 4608-4610.10.1016/j.transproceed.2010.09.170
    Search in Google Scholar
  5. 5. McDONALD GB. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology. 2010; 51: 1450-1460.10.1002/hep.23533
    Search in Google Scholar
  6. 6. DEL CAMPO L, LEÓN NG, PALACIOS DC, LAGANA C, TAGARRO D. Abdominal complications following hematopoietic stem cell transplantation. Radiographics. 2014; 34: 396-412.10.1148/rg.342135046
    Search in Google Scholar
  7. 7. NORVELL JP. Liver disease after hematopoietic cell transplantation in adults. Transplant Rev (Orlando). 2015; 29: 8-15.10.1016/j.trre.2014.08.001
    Search in Google Scholar
  8. 8. TOBIN LM, HEALY ME, ENGLISH K, MAHON BP. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clin Exp Immunol. 2013; 172: 333-348.10.1111/cei.12056
    Search in Google Scholar
  9. 9. AHMAD I, LABBÉ AC, CHAGNON M, BUSQUE L, COHEN S, KISS T, et al. Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011; 17: 1673-1678.10.1016/j.bbmt.2011.04.012
    Search in Google Scholar
  10. 10. PÉREZ-SIMON JA, ENCINAS C, SILVA F, ARCOS MJ, DÍEZ-CAMPELO M, SÁNCHEZ-GUIJO FM, et al. Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy. Biol Blood Marrow Transplant. 2008; 14: 1163-1171.10.1016/j.bbmt.2008.07.015
    Search in Google Scholar
  11. 11. FRIEDRICHS B, TICHELLI A, BACIGALUPO A, RUSSEL NH, RUUTU T, SHAPIRA MY, et al. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. Lancet Oncol. 2010; 11: 331-338.10.1016/S1470-2045(09)70352-3
    Search in Google Scholar
  12. 12. TICHELLI A, GRATWOHL A. Vascular endothelium as ‘novel’ target of graft-versus-host disease. Best Pract Res Clin Haematol. 2008; 21: 139-148.10.1016/j.beha.2008.02.00218503982
    Search in Google Scholar
  13. 13. KIM I, KEAM B, LEE KH, KIM JH, OH SY, RA EK, et al. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2007; 21: 207-213.10.1111/j.1399-0012.2006.00624.x17425746
    Search in Google Scholar
  14. 14. MARTÍNEZ-BRAVO MJ, TALLÓN I, ESPIGADO I, PEREZ-SIMÓN JA, PÉREZ-ROMERO P, GRACIA-AHUFINGER I, et al. Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease. Immunol Lett. 2011; 141: 140-144.10.1016/j.imlet.2011.09.00521968078
    Search in Google Scholar
  15. 15. PIDALA J, BLOOM GC, ENKEMANN S, ESCHRICH S, LANCASTER J, ANASETTI C. Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010; 16: 729-738.10.1016/j.bbmt.2009.11.00919922809
    Search in Google Scholar
  16. 16. HOSSAIN MS, ROBACK JD, POLLACK BP, JAYE DL, LANGSTON A, WALLER EK. Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood. 2007; 109: 4548-4556.10.1182/blood-2006-04-017442188550117289817
    Search in Google Scholar
  17. 17. TEN HOVE WR, VERSPAGET HW, BARGE R, LAMERS CB, VAN HOEK B. Liver chimerism after allogeneic blood stem cell transplantation. Transplant Proc. 2007; 39: 231-236.10.1016/j.transproceed.2006.10.02217275511
    Search in Google Scholar
  18. 18. WEN HS, WANG JM, ZHOU H, GONG SI, GAO L, WU Y. Migration and activation of T cells during development of graft-versus-host disease in a mouse model. Transplant Proc. 2013; 45: 713-718.10.1016/j.transproceed.2012.12.00423498811
    Search in Google Scholar
  19. 19. ALI SA, SHAH V, McKINNON R, VAN HARN M, JANAKIRAMAN N. Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form. Transpl Immunol. 2010; 23: 77-80.10.1016/j.trim.2010.03.00220230895
    Search in Google Scholar
  20. 20. MIYAZAKI T, DOY M, UNNO R, HONDA A, IKEGAMI T, ITOH S, et al. Regulatory T cells and liver pathology in a murine graft versus host response model. Hepatol Res. 2009; 39: 585-594.10.1111/j.1872-034X.2009.00495.x19260998
    Search in Google Scholar
  21. 21. BRANDON JA, PEREZ J, JENNINGS CD, COHEN DA, SINDHAVA VJ, BONDADA S, et al. Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease. Am J Physiol Gastrointest Liver Physiol. 2010; 299: G602-613.10.1152/ajpgi.00511.2009295068620634434
    Search in Google Scholar
  22. 22. PAN B, ZHANG Y, SUN Y, CHENG H, WU Y, SONG G, et al. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice. Cytokine. 2014; 68: 69-75.10.1016/j.cyto.2014.04.00224845795
    Search in Google Scholar
  23. 23. CHENG H, ZENG LY, PAN B, SONG GL, TIAN J, CHEN C, et al. The role of Th17 cells in early onset of mice acute graft versus host disease. Zhonghua Xue Ye Xue Za Zhi. 2011; 32: 322-325.
    Search in Google Scholar
  24. 24. LIM JY, CHO BS, MIN CK, PARK G, KIM YJ, CHUNG NG, et al. Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunol Invest. 2014; 43 :41-53.10.3109/08820139.2013.84319124111544
    Search in Google Scholar
  25. 25. MacDONALD KP, ROWE V, FILIPPICH C, JOHNSON D, MORRIS ES, CLOUSTON AD, et al. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation. Biol Blood Marrow Transplant. 2004; 10: 373-385.10.1016/j.bbmt.2004.02.00215148491
    Search in Google Scholar
  26. 26. HILL GR, MORRIS ES, FUERY M, HUTCHINS C, BUTLER J, GRIGG A, et al. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF. Biol Blood Marrow Transplant. 2006; 12: 603-607.10.1016/j.bbmt.2006.03.00116737933
    Search in Google Scholar
  27. 27. EL-HAYEK JM, ROGERS TE, BROWN GR. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. J Leukoc Biol. 2005; 78: 1001-1007.10.1189/jlb.120473016081594
    Search in Google Scholar
  28. 28. BOUZZAOUI A, SPANEKO E, MUELLER G, MIKLOS S, HUBER E, HOLLER E, et al. Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes Immun. 2009; 10: 687-701.10.1038/gene.2009.4919571824
    Search in Google Scholar
  29. 29. WANG Z, MURPHY WJ. Relationship between CCR5 and acute graft-versus-host disease in murine bone marrow transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006; 14: 934-940.
    Search in Google Scholar
  30. 30. MIKLOS S, MUELLER G, CHANG Y, BOUZZAOUI A, SPANEKO E, SCHUBERT TE, et al. Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host disease. Int J Hematol. 2009; 89: 383-397.10.1007/s12185-009-0272-y19288173
    Search in Google Scholar
  31. 31. VIERLING JM, HREHA G, WANG H, BRAUN M. The role of biliary epithelial cells in the immunopathogenesis of nonsuppurative destructive cholangitis in murine hepatic graft-versus-host disease. Trans Am Clin Climatol Assoc. 2011; 122: 326-335.
    Search in Google Scholar
  32. 32. ZHANG JL, HOU CM, WEI YL, LI XY, SUN DJ, FENG JN, et al. Influence of excessive complement activation on pathological process of acute graft versus host disease in mice. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010; 18: 1585-1589.
    Search in Google Scholar
  33. 33. HASHINO S, KOBAYASHI S, TAKAHATA M, ONAZAWA M, NAKAGAWA M, KAWAMURA T, et al. Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer. Int J Clin Oncol. 2008; 13: 176-180.10.1007/s10147-007-0716-418463966
    Search in Google Scholar
  34. 34. MAHGEREFTEH SY, SOSNA J, BOGOT N, SHAPIRA MY, PAPPO O, BLOOM AI. Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology. 2011; 258: 660-671.10.1148/radiol.1010002521339345
    Search in Google Scholar
  35. 35. LEE JH, LEE JH, KIM DY, YUN SC, KIM SD, CHOI Y, et al. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia. Eur J Haematol. 2011; 87: 172-181.10.1111/j.1600-0609.2011.01646.x21599753
    Search in Google Scholar
  36. 36. YOU JY, YU YB, CHEN PC, TSAY SH, CHEN CC, HO CH, et al. Donor lymphocyte infusion induced acute hepatitis. J Chin Med Assoc. 2004; 67: 411-415.
    Search in Google Scholar
  37. 37. RADHAKRISHNAN K, BISHOP J, JIN Z, KOTHARI K, BHATIA M, GEORGE D, et al. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013; 19: 912-917.10.1016/j.bbmt.2013.02.01923467127
    Search in Google Scholar
  38. 38. PIDALA J, CHAI X, KURLAND BF, INAMOTO Y, FLOWERS ME, PALMER J, et al. Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study. Biol Blood Marrow Transplant. 2013; 19: 784-791.10.1016/j.bbmt.2013.02.001389621523395601
    Search in Google Scholar
  39. 39. PARALKAR VR, GORADIA A, LUGER SM, LOREN AW. Severe eosinophilia as a manifestation of acute graft-versus-host disease. Oncology. 2008; 75: 134-136.10.1159/00015522418791329
    Search in Google Scholar
  40. 40. LESESVE JF, ALLA F, DUGUÉ F, SALIGNAC S, CLÉMENT L, LECOMPTE T, et al. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation. Int J Lab Hematol. 2011; 33: 343-356.10.1111/j.1751-553X.2010.01292.x21284831
    Search in Google Scholar
  41. 41. ZIDAN H, LO S, WIEBE D, TALANO J, ALEMZADEH R. Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver. Pediatr Blood Cancer. 2008; 50: 1280-1281.10.1002/pbc.2152218286546
    Search in Google Scholar
  42. 42. YEH SP, LIAO YM, LO WJ, LIN CL, BAI LY, LIN CY, et al. Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease. PLoS One. 2012; 7: e44416.10.1371/journal.pone.0044416343412822957070
    Search in Google Scholar
  43. 43. MAENG H, LEE JH, CHEONG JW, LEE ST, HAHN JS, KO YW, et al. Chronic graft-versus-host disease of the liver presenting as an acute hepatitis following nonmyeloablative hematopoietic stem cell transplantation. Int J Hematol. 2004; 79: 501-504.10.1532/IJH97.A1031915239404
    Search in Google Scholar
  44. 44. MELÍN-ALDANA H, THORMANN K, DUERST R, KLETZEL M, JACOBSOHN DA. Hepatitic pattern of graft versus host disease in children. Pediatr Blood Cancer. 2007; 49: 727-730.10.1002/pbc.2106917066458
    Search in Google Scholar
  45. 45. PROCHOREC-SOBIESZEK M, NASILOWSKA-ADAMSKA B, SZUMERA-CIEĆKIEWICZ A, TOMASZEWSKA A, HALABURDA K, SZCZEPIŃSKI A, et al. The significance of oral labial biopsy in hepatic graft-versus-host disease diagnosis in patients following allogeneic hematopoietic stem cell transplantation--a preliminary report. Ann Transplant. 2012; 17: 85-92.10.12659/AOT.883462
    Search in Google Scholar
  46. 46. VAN DER EIJK AA, PAS SD, CORNELISSEN JJ, DE MAN RA. Hepatitis E virus infection in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis. 2014; 27: 309-315.10.1097/QCO.000000000000007624977683
    Search in Google Scholar
  47. 47. LUFT T, COZELMANN M, BENNER A, RIEGER M, HESS M, STROHHAECKER U, et al. Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood. 2007; 110: 4535-4542.10.1182/blood-2006-10-04981717702900
    Search in Google Scholar
  48. 48. DÖRING M, ROHRER KM, ERBACHER A, GIESEKE F, SCHWARZE CP, BADER P, et al. Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation. Ann Hematol. 2015; 94: 265-273.10.1007/s00277-014-2185-y25113134
    Search in Google Scholar
  49. 49. LEE DH, HUH SJ, YOON HH, LEE SW, KIM KH, KIM SH. Clinical significance of anti-mitochondrial antibodies in a patient with chronic graft-versus-host disease following hematopoietic stem cell transplantation. Korean J Hematol. 2011; 46: 200-202.10.5045/kjh.2011.46.3.200320820522065977
    Search in Google Scholar
  50. 50. ERTURK SM, MORTELÉ KJ, BINKERT CA, GLICKMAN JN, OLIVA MR, ROS PR, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. AJR Am J Roentgenol. 2006; 186: 1497-1501.10.2214/AJR.05.053916714636
    Search in Google Scholar
  51. 51. McDONALD GB. Review article: management of hepatic disease following haematopoietic cell transplant. Aliment Pharmacol Ther. 2006; 24: 441-452.10.1111/j.1365-2036.2006.03001.x16886910
    Search in Google Scholar
  52. 52. DEEG HJ, SPAULDING E, SHULMAN HM. Iron overload, hematopoietic cell transplantation, and graft-versus-host disease. Leuk Lymphoma. 2009; 50: 1566-1572.10.1080/10428190903144659288772819863335
    Search in Google Scholar
  53. 53. KAMBLE RT, SELBY GB, MIMS M, KHARFAN-DABAJA MA, OZER H, GEORGE JN. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006; 12: 506-510.10.1016/j.bbmt.2006.01.00416635785
    Search in Google Scholar
  54. 54. ZHAO J, REN H, QIU Z, WANG M, LIU W, XU W, et al. The influence of liver dysfunction before transplantation and during conditioning period on the outcome of allogeneic hematopoietic stem cell transplantation. Zhonghua Nei Ke Za Zhi. 2014; 53: 99-103.
    Search in Google Scholar
  55. 55. PAVLETIC SZ, SMITH LM, BISHOP MR, LYNCH JC, TARANTOLO SR, VOSE JM, et al. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol. 2005; 78: 265-274.10.1002/ajh.2027515795914
    Search in Google Scholar
  56. 56. WOJNAR J, GIEBEL S, HOLOWIECKA-GORAL A, MARKIEWICZ M, WYLEZOL I, KOPERA M, et al. Prediction of nonrelapse mortality for patients surviving 100 days after allogeneic hematopoietic stem cell transplantation. Transplant Proc. 2007; 39: 3375-3379.10.1016/j.transproceed.2007.03.11118089388
    Search in Google Scholar
  57. 57. KANSU E. Thrombosis in stem cell transplantation. Hematology. 2012; 17 Suppl 1: S159-162.10.1179/102453312X1333616915673522507809
    Search in Google Scholar
  58. 58. SONG MK, CHUNG JS, KIM S, SEOL YM, KIM SG, SHIN HJ, et al. Hepatic artery resistance index at doppler ultrasonography is a useful parameter of hepatic graft-vs-host disease after allogeneic stem cell transplantation. Transplant Proc. 2010; 42: 3717-3722.10.1016/j.transproceed.2010.08.04121094845
    Search in Google Scholar
  59. 59. SILVA F, PÉREZ-SIMÓN JA, CABALLERO VELAZQUEZ T, ENCINAS C, SÁNCHEZ-GUIJO FM, DÍEZ-CAMPELO M, et al. Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant. Am J Hematol. 2010; 85: 290-293.10.1002/ajh.2161320162543
    Search in Google Scholar
  60. 60. BURNIER L, SALLER F, KADI L, BRISSET AC, SUGAMELE R, BAUDINO L, et al. Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease. Blood. 2010; 115: 3390-3397.10.1182/blood-2009-02-206920285848220139094
    Search in Google Scholar
DOI: https://doi.org/10.1515/rjim-2016-0011 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 83 - 92
Submitted on: Aug 12, 2015
|
Published on: May 20, 2016
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
allogeneic peripheral stem cell transplantation,
apoptosis,
graft versus host disease,
liver,
mesenchymal stem cells,
tumor necrosis factor
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2016 R.-G. Mihăilă, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 54 (2016): Issue 2 (June 2016)Next article